Protective Effects of Cuscuta australis Against CCl4-Induced Hepatic Injury in Rats: Antioxidant, Anti-Inflammatory, and In Silico Insights
Authors:
- Hanen BaccariHBHanen Baccari
- Arij BedouiABArij Bedoui
- Anouar FerianiAFAnouar Feriani
- Amal BouallegueABAmal Bouallegue
- Nihad SahriNSNihad Sahri
- Sohaib KhatibSKSohaib Khatib
- Mohamed KharratMKMohamed Kharrat
- Nizar TliliNTNizar Tlili
- Mansour SobehMSMansour Sobeh
- Moez AmriMAMoez Amri
- Zouhaier AbbesZAZouhaier Abbes
Open Access
- 10 October 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 18 (10) , 1524
Abstract
Background/Objectives: The search for new bioactive molecules increasingly extends beyond conventional medicinal plants, highlighting the importance of exploring alternative botanical sources. Parasitic plants represent a promising but underexploited reservoir of pharmacologically relevant compounds. Cuscuta australis (CA), a parasitic species with a history of traditional use, remains poorly characterized. This study aimed to investigate its phytochemical composition and evaluate its antioxidant, anti-inflammatory, and hepatoprotective properties. Methods: The phytochemical profile of CA extract was characterized by LC-MS. Antioxidant capacity was assessed using DPPH and ABTS assays. In vivo hepatoprotection was evaluated in male rats subjected to CCl4-induced hepatotoxicity and treated orally with CA (30 or 60 mg/kg body weight). Biochemical, lipid, oxidative stress, and histological parameters were determined. Molecular docking was conducted to predict the binding of major identified compounds against selected protein targets. Results: CA significantly and dose-dependently improved biochemical and histological markers. At 60 mg/kg, ALT, AST, ALP, and bilirubin were reduced by 32%, 33%, 63%, and 51%, respectively. Lipid metabolism was improved by decreased TC, TG, and LDL-C with increased HDL-C. Antioxidant defense was enhanced through elevated CAT, SOD, and GPx activities, accompanied by reduced MDA levels. TNF-α and IL-6 decreased by 48% and 53%, respectively. Histopathology confirmed hepatoprotection and reduced fibrosis. Docking studies revealed strong binding affinities (−7.07 to −19.20 kcal/mol) for several metabolites, notably quercetin glucoside, diosmetin glucoside, caffeic acid glucoside, feruloylquinic acid, and isorhamnetin glucoside, against CYP450, IL-2, TNF-α, and IL-6. Conclusions: These findings demonstrate that C. australis is a promising source of bioactive compounds with hepatoprotective, antioxidant, antihyperlipidemic, and anti-inflammatory effects, supporting its potential as a natural therapeutic agent.Keywords
This publication has 71 references indexed in Scilit:
- Hepatotoxic effects of environmentally relevant concentrations of polystyrene microplastics on senescent Zebrafish (Danio rerio): Patterns of stress response and metabolomic alterationsAquatic Toxicology, 2025
- Diosmetin alleviates TNFα-induced liver inflammation by improving liver sinusoidal endothelial cell dysfunctionBiomedicine & Pharmacotherapy, 2025
- Efficacy of Ma'aljobon Aftimouni (Cuscuta Reflexa and whey) on HbA1c and blood glucose levels in patients with Type 2 Diabetes: A randomized triple-blind clinical trialContemporary Clinical Trials Communications, 2024
- HPLC-QTOF-MS analysis of Polygonum maritimum aerial parts extract and focus on the therapeutic potential against ethylene glycol-induced lithiasis in ratsFood Bioscience, 2023
- Mechanism for the selective uptake of macular carotenoids mediated by the HDL cholesterol receptor SR-BIExperimental Eye Research, 2023
- Hepatoprotective effect of Cordia rothii extract against CCl4-induced oxidative stress via Nrf2–NFκB pathwaysBiomedicine & Pharmacotherapy, 2022
- In vivo evaluation and molecular docking studies of Schinus molle L. fruit extract protective effect against isoproterenol-induced infarction in ratsEnvironmental Science and Pollution Research, 2022
- Zygophyllum album leaves extract prevented hepatic fibrosis in rats, by reducing liver injury and suppressing oxidative stress, inflammation, apoptosis and the TGF-β1/Smads signaling pathways. Exploring of bioactive compounds using HPLC–DAD–ESI–QTOF-MS/MSInflammopharmacology, 2020
- Parasitic angiosperms: How often and how many?Taxon, 2020
- Interleukin 2 Promotes Hepatic Regulatory T Cell Responses and Protects From Biliary Fibrosis in Murine Sclerosing CholangitisHepatology, 2018